Australia markets open in 3 hours 5 minutes

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
24.44+0.82 (+3.47%)
At close: 04:00PM EDT
24.44 0.00 (0.00%)
After hours: 04:24PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
Operating expenses
Research development
180,317
161,855
103,303
50,294
Selling general and administrative
61,740
58,243
45,813
33,169
Total operating expenses
242,057
220,098
149,116
83,463
Operating income or loss
-242,057
-220,098
-149,116
-83,463
Total other income/expenses net
-1,027
-5,393
-3,274
-46,433
Income before tax
-242,647
-225,334
-152,166
-128,344
Income tax expense
0
0
-24
45
Income from continuing operations
-242,647
-225,334
-152,142
-128,389
Net income
-242,647
-225,334
-152,142
-128,389
Net income available to common shareholders
-242,647
-225,334
-152,142
-128,389
Basic EPS
-
-
-2.01
-1.01
Diluted EPS
-
-
-2.01
-1.01
Basic average shares
-
-
73,643
127,124
Diluted average shares
-
-
73,643
127,124
EBITDA
-
-217,367
-148,719
-83,286